Correlation of CCL8 expression with immune cell infiltration of skin cutaneous melanoma: potential as a prognostic indicator and therapeutic pathway
- PMID: 34844613
- PMCID: PMC8628426
- DOI: 10.1186/s12935-021-02350-8
Correlation of CCL8 expression with immune cell infiltration of skin cutaneous melanoma: potential as a prognostic indicator and therapeutic pathway
Abstract
Background: The tumor microenvironment (TME) is critical in the progression and metastasis of skin cutaneous melanoma (SKCM). Differences in tumor-infiltrating immune cells (TICs) and their gene expression have been linked to cancer prognosis. Given that immunotherapy can be effective against SKCM, we aimed to identify key genes that regulate the immunological state of the TME in SKCM.
Methods: Data from 471 SKCM patients in the The Cancer Genome Atlas were analyzed using ESTIMATE algorithms to generate an ImmuneScore, StromalScore, and EstimateScore for each patient. Patients were classified into low- or high-score groups based on median values, then compared in order to identify differentially expressed genes (DEGs). Then a protein-protein interaction (PPI) network was developed, and a prognostic model was created using uni- and multivariate Cox regression as well as the least absolute shrinkage and selection operator (LASSO). Key DEGs were identified using the web-based tool GEPIA. Profiles of TIC subpopulations in each patient were analyzed using CIBORSORT, and possible correlations between key DEG expression and TICs were explored. Levels of CCL8 were determined in SKCM and normal skin tissue using immunohistochemistry.
Results: Two scores correlated positively with the prognosis of SKCM patients. Comparison of the low- and high-score groups revealed 1684 up-regulated and 18 down-regulated DEGs, all of which were enriched in immune-related functions. The prognostic model identified CCL8 as a key gene, which CIBERSORT found to correlate with M1 macrophages. Immunohistochemistry revealed strong expression in SKCM tissue, but failed to detect the protein in normal skin tissue.
Conclusions: CCL8 is a potential prognostic marker for SKCM, and it may become an effective target for melanoma in which M1 macrophages play an important role.
Keywords: M1 macrophages; Skin cutaneous melanoma; Tumor microenvironment; Tumor-infiltrating immune cells.
© 2021. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.Front Cell Dev Biol. 2021 Oct 1;9:739594. doi: 10.3389/fcell.2021.739594. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34660598 Free PMC article.
-
Identification of a novel tumour microenvironment-based prognostic biomarker in skin cutaneous melanoma.J Cell Mol Med. 2021 Dec;25(23):10990-11001. doi: 10.1111/jcmm.17021. Epub 2021 Nov 10. J Cell Mol Med. 2021. PMID: 34755462 Free PMC article.
-
Identification of anoikis-related subtypes and development of risk stratification system in skin cutaneous melanoma.Heliyon. 2023 May 9;9(5):e16153. doi: 10.1016/j.heliyon.2023.e16153. eCollection 2023 May. Heliyon. 2023. PMID: 37215879 Free PMC article.
-
Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 May 28;48(5):671-681. doi: 10.11817/j.issn.1672-7347.2023.230069. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 37539569 Free PMC article. Chinese, English.
-
Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.Biosci Rep. 2022 Feb 25;42(2):BSR20212523. doi: 10.1042/BSR20212523. Biosci Rep. 2022. PMID: 35083488 Free PMC article. Review.
Cited by
-
Melanoma molecular subtyping and scoring model construction based on ligand-receptor pairs.Front Genet. 2023 Jan 26;14:1098202. doi: 10.3389/fgene.2023.1098202. eCollection 2023. Front Genet. 2023. PMID: 36777724 Free PMC article.
-
Pathogenic Th2 Cytokine Profile Skewing by IFN-γ-Responding Vitiligo Fibroblasts via CCL2/CCL8.Cells. 2023 Jan 4;12(2):217. doi: 10.3390/cells12020217. Cells. 2023. PMID: 36672151 Free PMC article.
-
Targeting Members of the Chemokine Family as a Novel Approach to Treating Neuropathic Pain.Molecules. 2023 Jul 30;28(15):5766. doi: 10.3390/molecules28155766. Molecules. 2023. PMID: 37570736 Free PMC article. Review.
-
Comprehensive scRNA-seq Analysis and Identification of CD8_+T Cell Related Gene Markers for Predicting Prognosis and Drug Resistance of Hepatocellular Carcinoma.Curr Med Chem. 2024;31(17):2414-2430. doi: 10.2174/0109298673274578231030065454. Curr Med Chem. 2024. PMID: 37936457
-
Personalized identification and characterization of genome-wide gene expression differences between patient-matched intracranial and extracranial melanoma metastasis pairs.Acta Neuropathol Commun. 2024 Apr 24;12(1):67. doi: 10.1186/s40478-024-01764-5. Acta Neuropathol Commun. 2024. PMID: 38671536 Free PMC article.
References
-
- Welch HG, Mazer BL, Adamson AS. The rapid rise in cutaneous melanoma diagnoses. N Engl J Med. 2021;384(1):72–79. - PubMed
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. - PubMed
-
- Singh A, Fatima K, Srivastava A, Khwaja S, Priya D, Singh A, et al. Anticancer activity of gallic acid template-based benzylidene indanone derivative as microtubule destabilizer. Chem Biol Drug Des. 2016;88(5):625–634. - PubMed
-
- Guo J, Qin S, Liang J, Lin T, Lu S, Chen X, et al. Chinese guidelines on the diagnosis and treatment of melanoma (2015 Edition) Chin Clin Oncol. 2016;5(4):57. - PubMed
-
- Sathish Kumar B, Kumar A, Singh J, Hasanain M, Singh A, Fatima K, et al. Synthesis of 2-alkoxy and 2-benzyloxy analogues of estradiol as anti-breast cancer agents through microtubule stabilization. Eur J Med Chem. 2014;86:740–751. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources